Comparing ARIA‐E severity scales and effects of treatment management thresholdsGregory Klein, Derk D. Purcell, Marzia A. Scelsi et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2022Cited by 12
Validation of 3‐ and 5‐point severity scales to assess ARIA‐ELuc Bracoud, Joyce Suhy, Gregory Klein et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2023Cited by 10
[P1–047]: VALIDATION OF A SIMPLE SEVERITY SCALE FOR ASSESSING ARIA‐ELuc Bracoud, Joyce Suhy, Derk D. Purcell et al.|Alzheimer s & Dementia|2017Cited by 3
Calibration of a simplified ARIA‐E MRI severity scale suitable for clinical practiceGregory Klein, Geoffrey A. Kerchner, Luc Bracoud et al.|Alzheimer s & Dementia|2020Cited by 3
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer’s Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, Martin Tolar, P. Murali Doraiswamy et al.|CNS Drugs|2025Cited by 2